arrow
D

Dimpy P. Shah

University of Texas and MD Anderson
H指数:41
被引数:7,477

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits

连锁不平衡评分回归识别肝细胞癌与临床相关性状之间的遗传相关性

2025-09-270
OAAI
Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America

全基因组关联研究确定北美肝细胞癌的高影响易感位点

2024-02-205
OAAI
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

乳腺癌和新型冠状病毒肺炎患者的临床特征,种族不平等和结局: 新型冠状病毒肺炎和癌症联盟 (CCC19) 队列研究

2023-10-172
OA
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
2023-07-227
OAAI
Patients Recently Treated for B-lymphoid MalignanciesShow Increased Risk of Severe COVID-19

最近接受B淋巴恶性肿瘤治疗的患者出现严重新型冠状病毒肺炎的风险增加

2022-03-0913
OA
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

老年癌症患者严重新型冠状病毒肺炎结局的老年危险因素: 来自新型冠状病毒肺炎和癌症协会的队列研究

2022-03-0115
OA
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

癌症和新型冠状病毒肺炎患者的合并感染: 新型冠状病毒肺炎和癌症协会 (CCC19) 研究

2022-02-149
OAAI
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19
2021-10-0121
OAAI
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

癌症患者的临床因素和近期抗癌治疗与新型冠状病毒肺炎严重程度的关系: 新型冠状病毒肺炎和癌症协会的报告

2021-06-01237
OAAI
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents
2020-12-300
OAAI
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
2020-10-01103
OAAI
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
LANCET
IF88.5
2020-06-011.3K
OAAI